LENTICURE

LIVE

Serial Number

98830214

Owner

LentiCure B.V.

Attorney

Jessica S. Sachs

Filing Date

Oct 31, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LENTICURE Trademark

Serial Number: 98830214 • Registration: 7887745

LENTICURE is a trademark filed by LentiCure B.V. on October 31, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

LentiCure B.V.

Dr. Molewaterplein 40
GD Rotterdam 3015 , NL

Entity Type: 99

Legal Representation

Attorney of Record

Jessica S. Sachs

2,238 trademarks filed View all →

Correspondence Address

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.

5445 Corporate Drive

Suite 200

Troy, MI 48098

United States

Trademark Details

Filing Date

October 31, 2024

Registration Date

August 12, 2025

Published for Opposition

June 24, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of metabolic, muscular, immune system and central nervous system related diseases and disorders; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Stem cells for medical purposes

Stem cell therapy services; Gene therapy services; Stem cell storage services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services in the field of metabolic, muscular, immune system and central nervous system related diseases and disorders; Collection and preservation of human genetic resources, namely, organs, tissues, cells and blood, for medical diagnosis and treatment

Gene therapy research; Stem cell research; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Research and development services in the field of medical and pharmaceutical preparations; Medical research laboratory services in the field of gene therapy; Laboratory research services relating to pharmaceuticals; Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; Medical development services, namely, custom manufacture of cells for diagnostic, medical and commercial applications in relation to cell and gene therapies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 12, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Aug 12, 2025 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 24, 2025 NPUB

PUBLISHED FOR OPPOSITION

Jun 24, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 18, 2025 NONP

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

May 23, 2025 ERRR

APPROVED FOR PUB - PRINCIPAL REGISTER

May 7, 2025 CNSA

EXAMINER'S AMENDMENT ENTERED

May 7, 2025 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 7, 2025 GNEN

EXAMINERS AMENDMENT E-MAILED

May 7, 2025 GNEA

EXAMINERS AMENDMENT -WRITTEN

May 7, 2025 CNEA

ASSIGNED TO EXAMINER

Apr 30, 2025 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 25, 2025 NWOS

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Feb 17, 2025 AMPX